Distribution of Liver Disease in Bangladesh: A Cross-country Study

Salimur Rahman1, Mohammad Faroque Ahmed2, Mohammad Jamshed Alam3

  • 1Department of Hepatology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh.

Insights

This study reveals a varied pattern of liver diseases across Bangladesh, with chronic liver diseases being most common. Acute hepatitis and nonviral infections also represent significant health concerns in the country.

Area of Science:

  • Gastroenterology and Hepatology
  • Public Health
  • Epidemiology

Background:

  • Hepatology is an emerging medical discipline in Bangladesh.
  • Understanding the landscape of liver diseases is crucial for public health planning.

Purpose of the Study:

  • To determine the distribution and patterns of liver diseases across Bangladesh.
  • To provide insights into regional variations in liver disease prevalence.

Main Methods:

  • A retrospective study analyzing data from 59,227 patients across seven administrative divisions.
  • Data collected between January 2012 and December 2013.

Main Results:

  • Only 13.2% of patients presenting with hepatology complaints were diagnosed with liver diseases; most had functional gastrointestinal disorders.
  • Chronic liver diseases (CLDs) constituted the majority (37-69%) of diagnosed liver conditions.
  • Acute hepatitis was common (approx. 20%), alongside nonviral infections like liver abscess and biliary ascariasis. CLD complications were less frequent in areas with better healthcare.

Conclusions:

  • Liver disease distribution in Bangladesh is heterogeneous, varying significantly by region.
  • The findings highlight the need for targeted public health interventions for liver diseases.
  • This study provides a foundational understanding of the hepatological disease burden in Bangladesh.
Abstract

Related Concept Videos

Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
2.1K
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
212
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
257